Press Release:
Armed Forces Institute of Pathology to Conduct NanoViricides Animal Studies against Bird Flu
? Business Wire 2008
2008-12-01 13:25:07 -
NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), announced today that they have executed a Cooperative Research and Development Agreement (CRADA) with the Armed Forces Institute of Pathology (AFIP). This joint R&D effort will enable AFIP scientists to test the effectiveness of several NanoViricides, Inc. anti-viral nanomedicines against deadly bird flu viruses (H5N1) at their facilities.
[snip]
The Company is developing anti-influenza drugs under the brand names FluCide", and FluCide-HP". FluCide is a broad-spectrum nanoviricide that mimics sialic acid, and therefore no influenza viruses (including bird flu) can escape it, no matter how much they mutate, say the Company scientists.
FluCide-HP is expected to be more effective against all highly pathogenic avian influenza (HPAI) viruses than is FluCide, according to the Company"s proprietary data. Any of the HPAI viruses may cause a potential pandemic, according to the World Health Organization (WHO). The most prevalent current HPAI virus is H5N1.
About AFIP
The Armed Forces Institute of Pathology (AFIP) (www.afip.org) is a tri-service agency of the Department of Defense specializing in pathology consultation, education and research.
The information contained in this press release does not necessarily reflect the position or the policy of the Government and no official endorsement should be inferred.
About NanoViricides:
NanoViricides, Inc. (www.nanoviricides.com) is a development stage company that is creating special purpose nanomaterials for viral therapy. The Company's novel nanoviricide" class of drug candidates are designed to specifically attack enveloped virus particles and to dismantle them. The Company is developing drugs against a number of viral diseases including H5N1 bird flu, seasonal influenza, HIV, hepatitis C, rabies, dengue fever, Ebola, and viral Epidemic Kerato-Conjunctivitis (EKC) among others.
http://www.pr-inside.com/armed-forces-institute-of-pathology-to-r943206.htm
Armed Forces Institute of Pathology to Conduct NanoViricides Animal Studies against Bird Flu
? Business Wire 2008
2008-12-01 13:25:07 -
NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), announced today that they have executed a Cooperative Research and Development Agreement (CRADA) with the Armed Forces Institute of Pathology (AFIP). This joint R&D effort will enable AFIP scientists to test the effectiveness of several NanoViricides, Inc. anti-viral nanomedicines against deadly bird flu viruses (H5N1) at their facilities.
[snip]
The Company is developing anti-influenza drugs under the brand names FluCide", and FluCide-HP". FluCide is a broad-spectrum nanoviricide that mimics sialic acid, and therefore no influenza viruses (including bird flu) can escape it, no matter how much they mutate, say the Company scientists.
FluCide-HP is expected to be more effective against all highly pathogenic avian influenza (HPAI) viruses than is FluCide, according to the Company"s proprietary data. Any of the HPAI viruses may cause a potential pandemic, according to the World Health Organization (WHO). The most prevalent current HPAI virus is H5N1.
About AFIP
The Armed Forces Institute of Pathology (AFIP) (www.afip.org) is a tri-service agency of the Department of Defense specializing in pathology consultation, education and research.
The information contained in this press release does not necessarily reflect the position or the policy of the Government and no official endorsement should be inferred.
About NanoViricides:
NanoViricides, Inc. (www.nanoviricides.com) is a development stage company that is creating special purpose nanomaterials for viral therapy. The Company's novel nanoviricide" class of drug candidates are designed to specifically attack enveloped virus particles and to dismantle them. The Company is developing drugs against a number of viral diseases including H5N1 bird flu, seasonal influenza, HIV, hepatitis C, rabies, dengue fever, Ebola, and viral Epidemic Kerato-Conjunctivitis (EKC) among others.
http://www.pr-inside.com/armed-forces-institute-of-pathology-to-r943206.htm